GGrantIndex
← Search

Leadership, Planning and Evaluation (LP&E)

$908,501P30FY2025CANIH

University Of California Los Angeles, Los Angeles CA

Investigators

Linked publications, trials & patents

Trial NCT07339085Trial NCT07276438Trial NCT07242365Trial NCT06650163Trial NCT06568016Trial NCT06113016Trial NCT05595499Trial NCT04205838Trial NCT04201873Trial NCT04185311Trial NCT04119024Trial NCT04106362Trial NCT04069923Trial NCT04069910Trial NCT04050215Trial NCT04007029Trial NCT03996850Trial NCT03970252Trial NCT03953157Trial NCT03904251Trial NCT03902951Trial NCT03892720Trial NCT03830918Trial NCT03825796Trial NCT03745690Trial NCT03732950Trial NCT03732352Trial NCT03672773Trial NCT03623854Trial NCT03618134Trial NCT03603223Trial NCT03601455Trial NCT03596710Trial NCT03582774Trial NCT03582475Trial NCT03541850Trial NCT03515577Trial NCT03506802Trial NCT03425461Trial NCT03411070Trial NCT03368547Trial NCT03319342Trial NCT03240861Trial NCT03202472Trial NCT03128619Trial NCT03025139Trial NCT03014804Trial NCT02940262Trial NCT02928510Trial NCT02925351Trial NCT02919332Trial NCT02902757Trial NCT02888301Trial NCT02881242Trial NCT02880020Trial NCT02879994Trial NCT02830165Trial NCT02816879Trial NCT02775292Trial NCT02756130Trial NCT02701153Trial NCT02688348Trial NCT02683200Trial NCT02672033Trial NCT02597894Trial NCT02575027Trial NCT02451865Trial NCT02336763Trial NCT02310594Trial NCT02296229Trial NCT02280161Trial NCT02263898Trial NCT02176902Trial NCT02070406Trial NCT02049593Trial NCT02048020Trial NCT02015559Trial NCT01912820Trial NCT01013285Trial NCT01005472Trial NCT00999557Trial NCT00998010Trial NCT00985192Trial NCT00955591Trial NCT00882765Trial NCT00880542Trial NCT00769470Trial NCT00706615Trial NCT00685516Trial NCT00616642Trial NCT00612066Trial NCT00601289Trial NCT00601094Trial NCT00521209Trial NCT00509431Trial NCT00471887Trial NCT00450567Trial NCT00444223Trial NCT00352001Trial NCT00349167

Abstract

LEADERSHIP, PLANNING AND EVALUATION ABSTRACT The UCLA Jonsson Comprehensive Cancer Center (JCCC) mission is to accelerate discoveries to prevent and cure cancer. JCCC Director Michael Teitell, MD, PhD (CMINT) led development of an ambitious 2019 – 2023 Strategic Plan that is ~83% complete, exceeding expectations, and a visionary 2024 – 2028 Strategic Plan that builds on progress with broad input from JCCC members and community, institutional, and affiliate leaders, and guidance from three advisory boards. Teitell has the necessary authorities and resources to lead the Center in all mission areas that span cancer research, education and training, community outreach and in-reach, and cancer clinical care in partnership with UCLA Health. He leads a ten member total CCSG Senior Leadership team that meets monthly or more to prioritize resources and activities for cancers with the greatest burden in the Los Angeles County (LAC) catchment area (e.g., breast, lung, prostate, and colorectal), as well as those that disproportionately affect specific populations (e.g., gastric and liver), using prospective planning, continuous improvement initiatives, and data-informed evaluations. An External Advisory Board (EAB), Community Advisory Committee (CAC), and Internal Advisory Board (IAB), provide feedback and share ideas, priorities, and perspectives that guide Center and community beneficial decision making and resource allocations for ongoing and opportunistic activities such as annual symposia, program meetings, topic-specific mini-retreats, workgroups, and new Center initiatives. JCCC governance is tiered with strategy and oversight committees, subcommittees, and workgroups for efficient development, implementation, and assessments of Plan strategy and tactic progress in all mission areas. Top-level, Cancer Center strategic leadership committees include a Vice Chancellor’s Cancer Steering Committee for institutional direction and cancer enterprise resourcing, a Cancer Research Council overseeing CCSG components and JCCC operations, and an Executive Cancer Committee leading cancer clinical program strategy for UCLA Health. Working with and reporting into these leadership committees are topic-specific, operational subcommittees and workgroups that implement initiatives and provide data and updates on progress. There are four Specific Aims for Center Leadership, Planning and Evaluation. Aim 1 is to plan, set, and implement infrastructure, community, and scientific aims of the 2024 – 2028 JCCC Strategic Plan. Aim 2 is to operate a collaborative leadership team of subject matter experts to guide Center progress. Aim 3 is to measure and evaluate mission progress with EAB, CAC, and IAB experts and the JCCC research community, with mechanisms for course correction, when needed. Aim 4 is to prioritize and efficiently allocate Center resources for LAC-guided, impactful JCCC research. Reliable JCCC Senior Leader tools are many, including staffing personnel, financial resources, and assignable space, to advance beneficial Center and LAC catchment area priorities.

View original record on NIH RePORTER →